Sumitomo Mitsui Trust Group Inc. Has $103.07 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Humana Inc. (NYSE:HUM) by 0.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 325,409 shares of the insurance provider’s stock after buying an additional 2,027 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.27% of Humana worth $103,070,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the period. Creative Financial Designs Inc. ADV lifted its position in shares of Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the period. Atwood & Palmer Inc. acquired a new position in shares of Humana in the 3rd quarter worth approximately $29,000. Hantz Financial Services Inc. acquired a new position in shares of Humana in the 2nd quarter worth approximately $35,000. Finally, Family Firm Inc. acquired a new position in shares of Humana in the 2nd quarter worth approximately $37,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of HUM stock opened at $289.85 on Thursday. The firm has a market capitalization of $34.90 billion, a PE ratio of 25.67, a price-to-earnings-growth ratio of 2.21 and a beta of 0.52. The firm has a fifty day simple moving average of $286.27 and a two-hundred day simple moving average of $332.44. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Analysts forecast that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.22%. Humana’s payout ratio is 31.36%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on HUM shares. UBS Group dropped their price target on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Jefferies Financial Group downgraded shares of Humana from a “buy” rating to a “hold” rating and dropped their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. KeyCorp started coverage on shares of Humana in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Stephens restated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research report on Wednesday, October 9th. Finally, Truist Financial dropped their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday, October 11th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.